Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Study finds most cancer patients exposed to misinformation. Researchers pilot ‘information prescription’

Written by | 2 Oct 2025

Ninety-three percent of patients with a new cancer diagnosis were exposed to at least one type of misinformation about cancer treatments, a UF Health Cancer Center study has found. Most patients… read more.

New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds

Written by | 21 Sep 2024

As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications. A new study finds that… read more.

One in five people with cancer participate in medical research studies

Written by | 5 Apr 2024

Researchers from Fred Hutchinson Cancer Center, the American Cancer Society Cancer Action Network and peer institutions released new findings in the Journal of Clinical Oncology showing that when all types of cancer research studies are… read more.

More proof that too many medications leads to adversity for older cancer patients

Written by | 2 Mar 2023

When older adults with cancer take multiple medications — including ordinary drugs like blood pressure pills, supplements, or antacids — it can result in more toxic chemotherapy side… read more.

One in two cancer patients may develop long COVID, with risk higher in women

Written by | 12 Feb 2023

More than one in two cancer patients at a US cancer centre experienced symptoms of long COVID-19 for more than six months after initial infection, according to a… read more.

Comparing the cost-effectiveness of treatments for blood clots in cancer patients

Written by | 29 Dec 2022

Research conducted by UC Davis Comprehensive Cancer Center and the University of Cincinnati shows that direct oral anti-coagulant (DOAC) drugs are more effective and are more cost-effective than low molecular weight heparin (LMWH) for… read more.

Hospital parking fees contribute to financial toxicity for cancer patients

Written by | 9 Dec 2022

Transportation to and from cancer centers for outpatient cancer treatments has been identified as one of the two most impactful out-of-pocket costs that cancer patients and their families… read more.

Pralsetinib therapy shows high response in range of cancer patients with RET gene fusions

Written by | 20 Aug 2022

In a Phase I/II trial, cancer treatment with pralsetinib has produced high response rates in patients with RET gene fusions, regardless of tumor type, researchers reported on Aug.12,… read more.

Leading radiotherapy researchers identify research priorities to improve outcomes for cancer patients

Written by | 19 Jul 2022

The NCRI Radiotherapy (CTRad) Group, a world-leading radiotherapy research group, has published its strategic priorities in radiotherapy research to address challenges in the field. The group has identified… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.